[Federal Register Volume 78, Number 78 (Tuesday, April 23, 2013)]
[Notices]
[Pages 23957-23958]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-09538]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances, Notice of Application, Lipomed

    Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this 
is notice that on January 29, 2013, Lipomed, One Broadway, Cambridge, 
Massachusetts 02142, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as an importer of the following 
basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
JWH-250 (6250).............................  I
SR-18 also known as RCS-8 (7008)...........  I
JWH-019 (7019).............................  I
JWH-081 (7081).............................  I
SR-19 also known as RCS-4 (7104)...........  I
JWH-122 (7122).............................  I
AM-2201 (7201).............................  I
JWH-203 (7203).............................  I
2C-T-2 (7385)..............................  I
JWH-398 (7398).............................  I
2C-D (7508)................................  I
2C-E (7509)................................  I
2C-H (7517)................................  I
2C-I (7518)................................  I
2C-C (7519)................................  I
2C-N (7521)................................  I
2C-P (7524)................................  I
2C-T-4 (7532)..............................  I
AM-694 (7694)..............................  I
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytical purposes.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedule I, which fall under the authority of 
section 1002(a)(2)(B) of the Act 21 U.S.C. 952(a)(2)(B) may, in the 
circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR Sec.  1301.43, and in such form as prescribed by 21 
CFR Sec.  1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than May 23, 2013.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR Sec.  1301.34(b), 
(c), (d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants 
for registration to import a basic class of any controlled substance in 
schedules I or II are, and will continue to be, required to demonstrate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, that the requirements for such 
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21

[[Page 23958]]

CFR Sec.  1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: April 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-09538 Filed 4-22-13; 8:45 am]
BILLING CODE 4410-09-P